CI Stock Analysis: Buy, Sell, or Hold?
CI - The Cigna Group
$279.05
-8.61 (-2.99%)
▼
5d:
-3.63%
30d:
+0.71%
90d:
-3.97%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 4.6/10
Get Alerted When CI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CI shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: CI shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$404.48
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$251.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CI is currently trading at $279.05, which is considered oversold relative to its 30-day fair value range of $279.79 to $294.93. The stock's valuation (Forward PE: 8.3) is in line with its historical norms (8.6). Remarkably, the market is currently pricing in an annual earnings decline of 1.1% over the next few years. This pessimistic expectation contrasts with the company's recent 29.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CI is in a uptrend. The price is currently testing key support at $278.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $340.92 (+22.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CI is in a uptrend. The price is currently testing key support at $278.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $340.92 (+22.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$279.79 -
$294.93
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.2% below Wall St target ($340.92)
Trading Range Analysis
30-Day Trading Range
$279.79 -
$294.93
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$278.97
Resistance Level
$304.69
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.33
Wall Street Target
$340.92
(+22.2%)
Revenue Growth (YoY)
4.6%
Earnings Growth (YoY)
29.1%
Profit Margin
2.3%
Valuation Discount vs History
-1.1% cheaper
PE vs Historical
8.3 vs 8.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.1%
(market-implied from PE analysis)
1-Year Target
$275.98
(-1%)
2-Year Target
$272.94
(-2%)
3-Year Target
$269.94
(-3%)
3-Yr Target (if PE normalizes)
(PE: 8→9)
$278.61
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 10.1%)
$926.00
(+232%)
Base:
(SPY PE: 8.3, Growth: 10.1%)
$372.21
(+33%)
Bear:
(PE: 7.1, Growth: 10.1%)
$316.38
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 12.56 | Current EPS (TTM): $22.90
Bull Case
$462.75
(+66%)
Analyst growth 46.2%, PE expands to 13.8
Base Case
$420.68
(+51%)
Market implied 46.2%, PE stable at 12.6
Bear Case
$195.61
(-30%)
Severe decline -20.0%, PE contracts to 10.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.3 to 8.6
Stabilization Target:
$288.01
(+3.2%)
PE Expansion Potential:
+3.2%
Share & Embed Analysis
Last updated: August 03, 2026 2:50 AM ET
Data refreshes hourly during market hours. Next update: 3:50 AM
Data refreshes hourly during market hours. Next update: 3:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CI showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Gilbert Ray Cisneros, Jr.
SELL
2026-03-13
Everett Neville
SELL
1719 shares
2026-03-02
Nicole S Jones
SELL
2307 shares
2026-03-02
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$114 | 51 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 50 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 55 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$408 | 54 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$71 | 43 HOLD |
Advanced CI Option Strategies
Professional options setups generated by AI based on today's CI price and gamma walls.
